Can I read Empagliflozin on EtoBox?
Empagliflozin by Gian Carlo is a document available to read on EtoBox.
What is Empagliflozin about?
1) The study examined the effects of empagliflozin (an SGLT2 inhibitor) on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes and coronary artery disease. 2) Patients were randomized to receive either empagliflozin 10 mg daily or placebo for 6 months. Blood samples were taken at baseline, 1 month, and 6 months to measure erythropoietin levels, iron indices, and red blood cell characteristics. 3) Preliminary results found that empagliflozin treatment was as
- Author
- Gian Carlo
- Language
- EN